Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study

Authors not listed

VA Office of Research and Development · 2007

Abstract

The purpose of the study is to determine the efficacy of methylphenidate over placebo in treating apathy in patients with Alzheimer's dementia. Apathy is one of the earliest and most profound disturbances that occur in Alzheimer's dementia (AD). Hypotheses: 1. Methylphenidate (MPH) will improve apathy significantly more than placebo in AD. 2\. Successful treatment of apathy will improve Instrumental Activities of Daily Living (IADLs), and caregiver burden.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-08 MST

Cite this

APA
Anonymous. (2007). Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study. <em>VA Office of Research and Development</em>. https://clinicaltrials.gov/study/NCT00495820
Vancouver
Anonymous. Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study. VA Office of Research and Development. 2007.
BibTeX
@misc{anon2007Methyl, title = {Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study}, author = {Anonymous}, journal = {VA Office of Research and Development}, year = {2007}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings